Statin News and Research

RSS

Statins are drugs used to lower cholesterol. Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries, narrowing or even blocking them.

NHS in Britain discriminates against the elderly

New research in Britain has revealed quite shocking information regarding the treatment of senior citizens in the health system.

14 Feb 2007

New assessment tool gives more accurate prediction of which women are at risk of heart disease

Researchers in the United states have developed a more accurate method of predicting if a woman is at risk of heart disease.

14 Feb 2007

Statins show extra benefit in raising "good" HDL cholesterol levels

New research suggests that popular statin drugs may not only lower levels of "bad" LDL cholesterol but also raise levels of "good" HDL cholesterol.

7 Feb 2007

Statins slow the progression of aortic valve stenosis

The trial provides the first prospective clinical evidence that aortic valves have an active biology that can be targeted with medical therapy and contradicts research published in 2005 in the New England Journal of Medicine, which concluded statins did not halt the progression of aortic stenosis.

30 Jan 2007

Virtual human metabolic network for medical science

Bioengineering researchers at UC San Diego have painstakingly assembled a virtual human metabolic network that will give researchers a new way to hunt for better treatments for hundreds of human metabolic disorders, from diabetes to high levels of cholesterol in the blood.

30 Jan 2007

Men with short telomeres may have a greater risk for heart disease

Men with short telomeres - repetitive strips of DNA that cap the ends of chromosomes - may have a higher risk of developing coronary heart disease than those with long telomeres, according to an Article in this week's issue of The Lancet.

14 Jan 2007

Use of statins and beta-blockers as prescribed following heart attack associated with living longer

New research suggests that the pharmacological effects of taking medications such as statins and beta-blockers as prescribed following a heart attack is associated with living longer, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.

9 Jan 2007

FDA announces tentative approval of generic Zoloft

Lupin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25mg, 50mg and 100mg.

2 Jan 2007

Angioplasty no better than drugs for heart attack victims who delay treatment

In what will come as a surprise to many doctors, researchers in the United States how found that contrary to current belief, heart attack survivors with mild or no symptoms who wait three days or more to seek medical help, will achieve little benefit from the procedures used to open clogged arteries.

15 Nov 2006

Food can have an impact in preventing cancer

With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.

14 Nov 2006

Pioglitazone may help slow progression of artery wall thickening

A medication given to diabetics to improve their body's sensitivity to insulin also appears to slow the thickening of their artery walls, according to a study posted online by JAMA: The Journal of the American Medical Association.

13 Nov 2006

Cost-effectiveness of lipid screening in Hodgkin's disease survivors

Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective, according to a study presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.

8 Nov 2006

Biomarkers in blood indicate likelihood of having another stroke

People who have just suffered their first ischemic stroke, a blood clot in the brain, often have elevated inflammatory biomarkers in their blood that indicate their likelihood of having another stroke or an increased risk of dying, according to Columbia University Medical Center researchers at NewYork-Presbyterian Hospital.

24 Oct 2006

Statins can significantly reduce the incidence of stroke, myocardial infarction

The study, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), showed that statins notably reduced such incidences in these nonrevascularized patients with chronic high cholesterol, as well.

23 Oct 2006

Combination therapy of salmeterol and fluticasone improves survival in patients with COPD

A combination of two common medications may help patients with chronic obstructive pulmonary disease (COPD) live longer.

23 Oct 2006

Statins show promise in slowing smoking-induced lung damage

In a new study presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), current and former smokers who used statins had lower lung function decline than those not using statins, regardless of whether patients continued or stopped smoking.

23 Oct 2006

TV advertising of prescription drugs may increase visits to doctor not actual sales

TV advertising of prescription drugs may be prompting more people to visit their doctors rather than substantially increasing sales of advertised drugs, according to research led by the Medical University of South Carolina (MUSC).

12 Sep 2006

Ultrasound targets angioplasty

World Congress of Cardiology 2006 - A simple technique - combining cardiac ultrasound with a heart muscle-stimulating drug - can identify the MI patients who would benefit most from angioplasty after thrombolysis, reports a study in Hot Line session II.

6 Sep 2006

Cardiovascular disease prevention program for Chile

World Congress of Cardiology Report - Fifty-five percent of the Chilean adult population is at risk of a cardiovascular event with a high rate of morbidity and mortality affecting mainly a productive population, between 35 and 74 years of age. This risk is 1.4 times greater for men.

5 Sep 2006

One of the largest Japanese cardiovascular trials confirms angiotensin receptor blockade protects people who have a wide range of cardiovascular diseases

The first controlled large-scale intervention trial of angiotensin receptor blockade in Japanese patients has confirmed that the cardiovascular protective effects of the drug valsartan is greater than to those seen with other therapies giving the same level of blood pressure control.

5 Sep 2006